Comparison of timothy grass pollen extract- and single major allergen-induced gene expression and mediator release in airway epithelial cells: A meta-analysis

Clinical and Experimental Allergy

Volumn 42, Issue 10, 2012, Pages 1479-1490

  Roschmann K I L ^a,d   van Kuijen, A M ^a   Luiten, S ^a   Jonker, M J ^b   Breit, T M ^b   Fokkens, W J ^a   Petersen, A ^c   van Drunen, C M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c RESEARCH CENTER BORSTEL   (Germany)

^d FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GRASS POLLEN EXTRACT; RNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; IMMUNE RESPONSE; MICROARRAY ANALYSIS; PHLEUM PRATENSE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RNA ISOLATION; SUPERNATANT;

ALLERGENS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; PHLEUM; PLANT EXTRACTS; POLLEN; RESPIRATORY SYSTEM;

EID: 84866606993     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.04033.x     Document Type: Article

References (62)

1. Nathan RA, Meltzer EO, Derebery J et al. The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 2008; 29:600-8.
2. Chapman MD. Allergen nomenclature. Clin Allergy Immunol 2008; 21:47-58.
3. Lowenstein H. Quantitative immunoelectrophoretic methods as a tool for the analysis and isolation of allergens. Prog Allergy 1978; 25:1-62.
4. Passalacqua G, Compalati E, Canonica GW. Advances in allergen-specific immunotherapy. Curr Drug Targets 2009; 10:1255-62.
5. Gastaminza G, Algorta J, Audicana M, Etxenagusia M, Fernandez E, Munoz D. Systemic reactions to immunotherapy: influence of composition and manufacturer. Clin Exp Allergy 2003; 33:470-4.
6. Mothes N, Valenta R, Spitzauer S. Allergy testing: the role of recombinant allergens. Clin Chem Lab Med 2006; 44:125-32.
7. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896-904.
8. Adam E, Hansen KK, Astudillo FO et al. The house dust mite allergen Der p 1, unlike Der p 3, stimulates the expression of interleukin-8 in human airway epithelial cells via a proteinase-activated receptor-2-independent mechanism. J Biol Chem 2006; 281:6910-23.
9. Asokananthan N, Graham PT, Stewart DJ et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 2002; 169:4572-8.
10. Hassim Z, Maronese SE, Kumar RK. Injury to murine airway epithelial cells by pollen enzymes. Thorax 1998; 53:368-71.
11. Osterlund C, Gronlund H, Polovic N, Sundstrom S, Gafvelin G, Bucht A. The non-proteolytic house dust mite allergen Der p 2 induce NF-kappaB and MAPK dependent activation of bronchial epithelial cells. Clin Exp Allergy 2009; 39:1199-208.
12. Roschmann K, Farhat K, Konig P, Suck R, Ulmer AJ, Petersen A. Timothy grass pollen major allergen Phl p 1 activates respiratory epithelial cells by a non-protease mechanism. Clin Exp Allergy 2009; 39:1358-69.
13. Shin SH, Lee YH. Airborne fungi induce nasal polyp epithelial cell activation and toll-like receptor expression. Int Arch Allergy Immunol 2010; 153:46-52.
14. Shreffler WG, Castro RR, Kucuk ZY et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol 2006; 177:3677-85.
15. Tai HY, Tam MF, Chou H et al. Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells. Allergy 2006; 61:382-8.
16. Holgate ST, Lackie P, Wilson S, Roche W, Davies D. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med 2000; 162:S113-S117.
17. Holgate ST, Davies DE, Puddicombe S et al. Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur Respir J Suppl 2003; 44:24s-9s.
18. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131:599-606.
19. Vroling AB, Jonker MJ, Luiten S, Breit TM, Fokkens WJ, van Drunen CM. Primary nasal epithelium exposed to house dust mite extract shows activated expression in allergic individuals. Am J Respir Cell Mol Biol 2008; 38:293-9.
20. Vroling AB, Fokkens WJ, van Drunen CM. How epithelial cells detect danger: aiding the immune response. Allergy 2008; 63:1110-23.
21. Roschmann KI, Luiten S, Jonker MJ et al. Timothy grass pollen extract-induced gene expression and signalling pathways in airway epithelial cells. Clin Exp Allergy 2011; 41:830-41.
22. van Tongeren J, Reinartz SM, Fokkens WJ, de Jong EC, van Drunen CM. Interactions between epithelial cells and dendritic cells in airway immune responses: lessons from allergic airway disease. Allergy 2008; 63:1124-35.
23. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008; 8:193-204.
24. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15:410-6.
25. Hammad H, Lambrecht BN. Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses. Allergy 2011; 66:579-87.
26. Aslam A, Lloyd-Lavery A, Warrell DA, Misbah S, Ogg GS. Common filaggrin null alleles are not associated with hymenoptera venom allergy in Europeans. Int Arch Allergy Immunol 2011; 154:353-5.
27. Brown SJ, Asai Y, Cordell HJ et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 2011; 127:661-7.
28. Koppelman GH, Meyers DA, Howard TD et al. Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med 2009; 180:929-35.
29. Roschmann KI, van Kuijen AM, Luiten S et al. Purified Timothy grass pollen major allergen Phl p 1 may contribute to the modulation of allergic responses through a pleiotropic induction of cytokines and chemokines from airway epithelial cells. Clin Exp Immunol 2012; 167:413-21.
30. Irizarry RA, Hobbs B, Collin F et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4:249-64.
31. Cui X, Churchill GA. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 2003; 4:210.
32. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3. Article3.
33. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990; 9:811-8.
34. Focke M, Marth K, Flicker S, Valenta R. Heterogeneity of commercial timothy grass pollen extracts. Clin Exp Allergy 2008; 38:1400-8.
35. Twardosz-Kropfmuller A, Singh MB, Niederberger V et al. Association of allergic patients' phenotypes with IgE reactivity to recombinant pollen marker allergens. Allergy 2010; 65:296-303.
36. Van der Veen MJ, Mulder M, Witteman AM et al. False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens. J Allergy Clin Immunol 1996; 98:1028-34.
37. Mari A. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data. Clin Exp Allergy 2003; 33:43-51.
38. Demoly P, Calderon MA. Dosing and efficacy in specific immunotherapy. Allergy 2011; 66:38-40.
39. Weghofer M, Thomas WR, Kronqvist M et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest 2008; 38:959-65.
40. Van der Linden IJ, de Groot MJ, de Jong NC, Bozkurt Z, Cobbaert CM. The diagnostic performance of allergen-molecules in comparison to allergen-extracts. Clin Chem Lab Med 2011; 50:129-32.
41. van der Veen MJ, Jansen HM, Aalberse RC, van der Zee JS. Der p1 and Der p2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response. Clin Exp Allergy 2001; 31:705-14.
42. Nouri-Aria KT, Wachholz PA, Francis JN et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004; 172:3252-9.
43. Wachholz PA, Nouri-Aria KT, Wilson DR et al. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios. Immunology 2002; 105:56-62.
44. Vroling AB, Jonker MJ, Breit TM, Fokkens WJ, van Drunen CM. Comparison of expression profiles induced by dust mite in airway epithelia reveals a common pathway. Allergy 2008; 63:461-7.
45. Mattila P, Renkonen J, Toppila-Salmi S et al. Time-series nasal epithelial transcriptomics during natural pollen exposure in healthy subjects and allergic patients. Allergy 2010; 65:175-83.
46. Renkonen J, Mattila P, Lehti S et al. Birch pollen allergen Bet v 1 binds to and is transported through conjunctival epithelium in allergic patients. Allergy 2009; 64:868-75.
47. Feo BF, Mur GP, Carnes J et al. Grass pollen, aeroallergens, and clinical symptoms in Ciudad Real, Spain. J Investig Allergol Clin Immunol 2010; 20:295-302.
48. Yli-Panula E, Fekedulegn DB, Green BJ, Ranta H. Analysis of airborne betula pollen in Finland; a 31-year perspective. Int J Environ Res Public Health 2009; 6:1706-23.
49. Platts-Mills TA, Woodfolk JA. Allergens and their role in the allergic immune response. Immunol Rev 2011; 242:51-68.
50. Pan J, Kunkel EJ, Gosslar U et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000; 165:2943-9.
51. Porter JC, Hall A. Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium. FASEB J 2009; 23:492-502.
52. Comeau MR, Ziegler SF. The influence of TSLP on the allergic response. Mucosal Immunol 2010; 3:138-47.
53. Escoubet-Lozach L, Glass CK, Wasserman SI. The role of transcription factors in allergic inflammation. J Allergy Clin Immunol 2002; 110:553-64.
54. Roth M, Black JL. Transcription factors in asthma: are transcription factors a new target for asthma therapy? Curr Drug Targets 2006; 7:589-95.
55. Yamashita M, Onodera A, Nakayama T. Immune mechanisms of allergic airway disease: regulation by transcription factors. Crit Rev Immunol 2007; 27:539-46.
56. Bacsi A, Choudhury BK, Dharajiya N, Sur S, Boldogh I. Subpollen particles: carriers of allergenic proteins and oxidases. J Allergy Clin Immunol 2006; 118:844-50.
57. Boldogh I, Bacsi A, Choudhury BK et al. ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest 2005; 115:2169-79.
58. Ying S, Meng Q, Barata LT, Kay AB. Macrophage inflammatory protein-1alpha and C-C chemokine receptor-1 in allergen-induced skin late-phase reactions: relationship to macrophages, neutrophils, basophils, eosinophils and T lymphocytes. Clin Exp Allergy 2001; 31:1724-31.
59. Lukacs NW, Standiford TJ, Chensue SW, Kunkel RG, Strieter RM, Kunkel SL. C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation. J Leukoc Biol 1996; 60:573-8.
60. Ramos CD, Canetti C, Souto JT et al. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J Leukoc Biol 2005; 78:167-77.
61. Beck LA, Dalke S, Leiferman KM et al. Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects. J Immunol 1997; 159:2962-72.
62. Lloyd CM, Rankin SM. Chemokines in allergic airway disease. Curr Opin Pharmacol 2003; 3:443-8.